Shujuan Jiang
- Immunology top 5%
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 4
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
-
- Lung Cancer Treatments and Mutations 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Cytomegalovirus and herpesvirus research 8
-
- RNA modifications and cancer 5
- RNA regulation and disease 3
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- ChinaUnited States
In The Last Decade
Shujuan Jiang
41 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 579
- Oncology 569
- Cancer Research 217
- Pulmonary and Respiratory Medicine 269
- Epidemiology 220
Countries citing papers authored by Shujuan Jiang
This map shows the geographic impact of Shujuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujuan Jiang more than expected).
Fields of papers citing papers by Shujuan Jiang
This network shows the impact of papers produced by Shujuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujuan Jiang. The network helps show where Shujuan Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shujuan Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 5 | |
| 4 | 2021 | 19 | |
| 5 | 2021 | 16 | |
| 6 | 2018 | 12 | |
| 7 | 2017 | 14 | |
| 8 | 2016 | 14 | |
| 9 | 2016 | 17 | |
| 10 | 2016 | 8 | |
| 11 | 2016 | 4 | |
| 12 | Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysisbreakdown → | 2015 | 717 |
| 13 | 2015 | 18 | |
| 14 | 2015 | 18 | |
| 15 | 2015 | 34 | |
| 16 | 2014 | 6 | |
| 17 | 2013 | 78 | |
| 18 | 2011 | 7 | |
| 19 | 2011 | 4 | |
| 20 | 2006 | 3 |
About Shujuan Jiang
Shujuan Jiang is a scholar working on Cancer Research, Developmental Biology and Pulmonary and Respiratory Medicine, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (8 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cancer-related molecular mechanisms research (3 papers) and RNA regulation and disease (3 papers). The work is most often cited by research in Immunology (579 citations), Oncology (569 citations) and Cancer Research (217 citations). Shujuan Jiang has collaborated with scholars based in China and United States. Frequent co-authors include Yao Liu, Bin Shang, Yi Liu, Lili Su, Fei Long, Daowei Li, Hui Qü, Song Zhang, Bin Liang and Yanping Ma. Their work appears in journals such as PLoS ONE, Scientific Reports and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.